Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model.

C. A. Ritter; R. Bianco; T. Dugger; J. Forbes; S. Qu; C. Rinehart; W. King; C. L. Arteaga

doi:10.5414/CPP42642

Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model.

C. A. Ritter, R. Bianco, T. Dugger, J. Forbes, S. Qu, C. Rinehart, W. King, C. L. Arteaga

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	642-643
Number of pages	2
Journal	International journal of clinical pharmacology and therapeutics
Volume	42
Issue number	11
DOIs	https://doi.org/10.5414/CPP42642
State	Published - Nov 2004

ASJC Scopus subject areas

General Medicine

Access to Document

10.5414/CPP42642

Cite this

@article{29aff76b0cdb49fa983cb7489548b3b5,

title = "Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model.",

author = "Ritter, {C. A.} and R. Bianco and T. Dugger and J. Forbes and S. Qu and C. Rinehart and W. King and Arteaga, {C. L.}",

year = "2004",

month = nov,

doi = "10.5414/CPP42642",

language = "English (US)",

volume = "42",

pages = "642--643",

journal = "International journal of clinical pharmacology and therapeutics",

issn = "0946-1965",

publisher = "Dustri-Verlag Dr. Karl Feistle",

number = "11",

}

TY - JOUR

T1 - Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model.

AU - Ritter, C. A.

AU - Bianco, R.

AU - Dugger, T.

AU - Forbes, J.

AU - Qu, S.

AU - Rinehart, C.

AU - King, W.

AU - Arteaga, C. L.

PY - 2004/11

Y1 - 2004/11

UR - http://www.scopus.com/inward/record.url?scp=16644385065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644385065&partnerID=8YFLogxK

U2 - 10.5414/CPP42642

DO - 10.5414/CPP42642

M3 - Article

C2 - 15598031

AN - SCOPUS:16644385065

SN - 0946-1965

VL - 42

SP - 642

EP - 643

JO - International journal of clinical pharmacology and therapeutics

JF - International journal of clinical pharmacology and therapeutics

IS - 11

ER -

Mechanisms of resistance development against trastuzumab (Herceptin) in an in vivo breast cancer model.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this